<?xml version="1.0" ?>


<rss version="2.0">
  <channel>
    <title>QUALITYSTOCKS</title>
    <subtitle>Welcome to QUALITYSTOCKS's Blog!</subtitle>
    <link>http://blogs.transworldnews.com/</link>
    <guid>http://blogs.transworldnews.com/</guid>
    <author>
        <name>Finditt</name>
    </author>
    <copyright>Copyright (c) 2010 Finditt.com</copyright>
    <language>en-us</language>

  <item>
    <title>Advaxis, Inc. (ADXS) and Jack Klugman</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180289</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180289</guid>
    <pubDate>Tue, 18 Jun 2013 17:35:55 GMT</pubDate>
    
    <category>Stocks</category>
    <description>When well-loved theater and television performer Jack Klugman died in December of 2012 at age 90, few people remembered an important role that the actor played in the country’s drug development process. Klugman, who had gained television fame as Oscar Madison in The Odd Couple, and later as a medical examiner in the long running series Quincy, was one of the earliest stars to use his celebrity to effectively drive social causes. 
In 1982, Klugman went to Washington and testified before Congress on behalf of the Orphan Drug Act. The idea was to provide various governmental supports to encourage pharmaceutical companies to invest in developing drugs for relatively small medical markets. Few people were aware of the need for such support until an episode of Quincy was broadcast in 1981, showing how many people suffered from diseases that went unresearched because they were considered unprofitable. Klugman was called to testify in support of the Act in 1982, and was instrumental in finally getting it passed in</description>
  </item>

  <item>
    <title>GRILLiT, Inc. (GRLT) is “One to Watch”</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180288</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180288</guid>
    <pubDate>Tue, 18 Jun 2013 17:35:22 GMT</pubDate>
    
    <category>Stocks</category>
    <description>GRILLiT was founded on the concept of delivering a fast-casual dining experience with fresh, nutritious home-style cooking. Leveraging more than four decades of experience in the food industry, the founders of GRILLiT established this unique business model to satisfy the ever-increasing demand for delicious and healthy food while providing the perfect ambiance for guest to relax and enjoy great cuisine.
The company sources its ingredients from local and domestic farmers to ensure crisp, fresh produce and grain-fed Angus beef. The cooking techniques and low-sodium recipes employed result in uniquely healthy and delectable meal choices. Using the best possible ingredients, GRILLiT chefs have created an inspiring flavor profile using fresh herbs spices and all-natural marinades.
The management team executing GRILLiT’s business strategy has been carefully assembled to achieve rapid growth and profitability. One of the most recent additions, Rob Elliott, brings more than 25 years of experience in restaurant</description>
  </item>

  <item>
    <title>Tungsten Corp. (TUNG) High Concentration Tungsten Anomalies Detected at Cherry Creek in Nevada</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180287</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180287</guid>
    <pubDate>Tue, 18 Jun 2013 17:34:48 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Tungsten Corp., the domestically focused tungsten developer which has put together a nice land package between their 2.3k-acre Cherry Creek property in Nevada and a second project in Idaho, at the historically-producing Wildhorse Mine property, reported today that analysis of the most recent survey data on Cherry Creek has kicked up a bunch of new, heavily-mineralized areas.
A battery of rock, soil, and stream sediment sampling from the last work phase, parsed by Carlin Trend Mining Services Ltd., over in Elko, shows several targets with high concentrations of tungsten mineralization, and the company is already raring to go for another round of sampling. Plans are to get an even more comprehensive survey worked up during this next phase of field work, set to commence directly, with the primary emphasis being on up-stream or other analytics designed to pin-point the sources of the observed tungsten anomalies.
Concentrations well above the economic threshold of 5ppm detected up-stream of areas located by the</description>
  </item>

  <item>
    <title>International Stem Cell Corp. (ISCO) Stem Cell Technology a Game Changer for Regenerative Medicine</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180286</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180286</guid>
    <pubDate>Tue, 18 Jun 2013 17:34:02 GMT</pubDate>
    
    <category>Stocks</category>
    <description>International Stem Cell Corp. is focused on treating diseases of the eye, nervous system, and liver by utilizing a new stem cell technology called parthenogenesis. The regenerative technology uses unfertilized eggs, sidestepping the controversial use of embryo stem cells, to address immune-rejection.
Stem cells not only have the ability to proliferate, but also to change (differentiate) into more specialized cells such as skin, liver, or blood cells. Because these “pluripotent” stem cells have the potential to become any cell in the body, they are considered the most powerful stem cells. 
The first type of pluripotent stem cells to be studied were embryonic stem cells, though the process is of considerable ethical question because creating embryonic stem cells involves the destruction of a fertilized human embryo. 
As an innovative alternative, ISCO has pioneered the development of human parthenogenetic stem cells (hpSCs), which are created by chemically stimulating unfertilized eggs (oocytes) to initiate</description>
  </item>

  <item>
    <title>Professional Diversity Network (IPDN) Announces Acquisition of Resunate Recruiting Technology Platform</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180280</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180280</guid>
    <pubDate>Tue, 18 Jun 2013 13:35:13 GMT</pubDate>
    
    <category>Stocks</category>
    <description>The Professional Diversity Network, a developer and operator of online networks and job boards for culturally diverse professionals, announced that it has acquired Resunate, a developer of recruiting software designed to connect job seekers, colleges, universities, and job placement companies with specific job postings.
Ressunate’s mission has been to increase the number of successful job placements through candidate provision of insight into how best to present oneself and which opportunities are best suited to the candidate. Through the acquisition, the company has gained a r&#233;sum&#233; optimization tool that is currently used by job seekers and career services offices in over 150 countries. The resume tool has proven to double an applicant’s interview rate through the use of interactive feedback on how to best tailor a resume for respective positions.
“This technology is extremely effective at securing interviews for our members while at the same time providing our recruitment clients with applications that</description>
  </item>

  <item>
    <title>Registered Direct Offering of $12.0 Million Completed by Elephant Talk Communications Corp. (ETAK)</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180279</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180279</guid>
    <pubDate>Tue, 18 Jun 2013 13:34:23 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Yesterday, Elephant Talk Communications Corp. announced the completion of a registered direct public offering of an aggregate $12.0 million, which was led by a $4.5 million investment from company CEO Steven van der Velden, a $5.0 million investment from Crede CG III Ltd. (a wholly owned subsidiary of Crede Capital Group LLC) and investors placed by Dawson James Securities to purchase an additional $2.5 million. The company sold an aggregate of 17,425,638 shares of common stock, par value $0.00001 per share, and warrants for purchasing up to an aggregate of 7,841,537 shares of common stock. 
The shares are being sold to non-affiliate investors at $0.682 per share and to the affiliated investor (van der Velden) at $0.70 per share. The warrants have an initial exercise price of $0.887 per warrant share for both the affiliated investor and the non-affiliated investors. NYSE MKT notified Elephant Talk Communications on June 13 of its acceptance of the company’s plan of compliance; this was one of the closing</description>
  </item>

  <item>
    <title>Cardium Therapeutics, Inc. (CXM) Builds Diverse Portfolio with Broad Commercialization Opportunities</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180278</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180278</guid>
    <pubDate>Tue, 18 Jun 2013 13:33:46 GMT</pubDate>
    
    <category>Stocks</category>
    <description>It’s not something you’d expect to find in a regenerative medicine company’s portfolio, but Cardium Therapeutics’ To Go Brands healthy nutraceutical supplement business is complementary to the company’s overarching mission of meeting unmet medical needs as part of an individual’s overall health and wellness. 
Cardium in October 2012 acquired the assets, business, and product portfolio of To Go Brands, which develops and markets more than 25 products including nutraceutical powder mixes, supplements, and chews to support healthy lifestyles. 
The brand’s Healthy To Go product line offers a host of healthy product offerings distributed through mass food and drug channels at retailers such as Whole Foods, CVS, Kroger, GNC, Vitamin Shoppe, and more. 
Within Cardium’s medical opportunities portfolio is its lead commercial product, Excellagen&#174;, topical gel for wound care management. Excellagen is FDA-approved for the marketing and sale in the United States. In addition to its plans to advance Excellagen’s</description>
  </item>

  <item>
    <title>Follow QualityStocks on Twitter!</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180277</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180277</guid>
    <pubDate>Tue, 18 Jun 2013 13:33:14 GMT</pubDate>
    
    <category>Stocks</category>
    <description>The equity markets are constantly moving and it is imperative that an active trader can find out what is happening in real-time. Even if you aren’t trading all day long – it is important to stay on top of the latest-breaking news. That is why we created our Twitter account just for you.
By following us at Twitter, you will be right on top of the action in the micro-cap and small-cap markets. You will receive short alerts regarding stock movements, news releases, and our new “Ones to Watch.” Every week we send dozens of tweets to bring our followers the hottest stocks and headlines.
The news about the quality of our Twitter service has spread rapidly. As of today, we have more than 115,000 followers.
If you like to start following us, please visit our page at: http://www.twitter.com/QualityStocks
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find,</description>
  </item>

  <item>
    <title>Noble Roman Inc. (NROM) Continues Expansion Efforts of Take’N’Bake Concept</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180276</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180276</guid>
    <pubDate>Tue, 18 Jun 2013 13:32:43 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Indianapolis based franchisor of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, Noble Roman, provided an update today on the continued expansion of its popular take-n-bake (TNB). The expansion currently targets grocery stores around the country as well as market growth of its stand-alone take-n-bake franchises.
The company has signed five new stand-alone TNB franchise agreements in the last two weeks alone, bringing the total number of take-n-bake franchises open or currently in development to 16 total. Of those, seven are currently in operation and open; the other nine are under construction and have tentative openings scheduled during the next several months.
Noble Roman will continue overall expansion efforts, including increasing the number of grocery stores offering Noble Roman’s Take-n-Bake pizza. As of today approximately 1,625 license agreements have been signed. Noble Roman has been steadily expanding its grocery network, promoting additional interest from grocery chains nationwide.</description>
  </item>

  <item>
    <title>Tolkonet, Inc.’s (TKOI) EthoStream Selected by Twenty Four Seven Hotels as Preferred HSIA Partner</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180274</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180274</guid>
    <pubDate>Tue, 18 Jun 2013 10:14:07 GMT</pubDate>
    
    <category>Stocks</category>
    <description>EthoStream, a division of Telkonet and one of the largest hospitality high-speed internet access (HSIA) network providers in America, today announced that Twenty Four Seven Hotels, a Hospitality Management Company based in Newport Beach, California, has selected EthoStream as its Preferred High-Speed Internet Access Provider.
“We’re very pleased to be partnering with Twenty Four Seven Hotels as their preferred HSIA provider throughout their properties. I believe our selection underscores the value EthoStream can deliver to customers that care deeply about all aspects of their guests’ stay,” stated Jason Tienor, CEO of Telkonet. “Providing the best internet access technology and customer service available to the hospitality industry is the reason more than 2,400 properties trust us to support their guests and we continue to add industry-leading clients with high expectations such as Twenty Four Seven Hotels.”
EthoStream’s “Total Solution” package is a comprehensive set of services needed to deliver quality</description>
  </item>

  <item>
    <title>BioRestorative Therapies, Inc. (BRTX) CEO Mark Weinreb Details Biotech Innovation in NBT Equities Research Interview</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180273</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180273</guid>
    <pubDate>Tue, 18 Jun 2013 10:13:21 GMT</pubDate>
    
    <category>Stocks</category>
    <description>BioRestorative Therapies CEO Mark Weinreb was recently interviewed by financial personality and founder of NBT Equities Research, Tobin Smith, to discuss the life science company’s medical procedures using cell and tissue protocols, specifically focusing on its “anti-biotech” business model and what the company is doing to positively impact the biotech industry. 
“We’ve come up with a hybrid approach enabling us to basically efficiently and economically … develop an enormous amount of science and with relevant data and move projects along in a very quick manner. We’ve been able to leverage many assets that are out there and instead of building a huge infrastructure and going through money very quickly; we’ve been able to control all of that and come up with incredible scientific programs,” Weinreb stated. 
The interview includes an update on BRTX’s ThermoStem™ Program, which is designed to develop treatments using brown fat stem cells for metabolic disorders and obesity. The program has a narrower focus of</description>
  </item>

  <item>
    <title>Tolkonet, Inc.’s (TKOI) EthoStream Selected by Twenty Four Seven Hotels as Preferred HSIA Partner</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180272</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180272</guid>
    <pubDate>Tue, 18 Jun 2013 10:12:41 GMT</pubDate>
    
    <category>Stocks</category>
    <description>EthoStream, a division of Telkonet and one of the largest hospitality high-speed internet access (HSIA) network providers in America, today announced that Twenty Four Seven Hotels, a Hospitality Management Company based in Newport Beach, California, has selected EthoStream as its Preferred High-Speed Internet Access Provider.
“We’re very pleased to be partnering with Twenty Four Seven Hotels as their preferred HSIA provider throughout their properties. I believe our selection underscores the value EthoStream can deliver to customers that care deeply about all aspects of their guests’ stay,” stated Jason Tienor, CEO of Telkonet. “Providing the best internet access technology and customer service available to the hospitality industry is the reason more than 2,400 properties trust us to support their guests and we continue to add industry-leading clients with high expectations such as Twenty Four Seven Hotels.”
EthoStream’s “Total Solution” package is a comprehensive set of services needed to deliver quality</description>
  </item>

  <item>
    <title>Rainbow Coral Corp. (RBCC) Partner Offers Cell Research Game Changer</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180257</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180257</guid>
    <pubDate>Mon, 17 Jun 2013 17:13:42 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Rainbow Coral’s partner, Nano3D Biosciences (n3D), is the creator of one of the newest 3D cell culturing technology on the market. Cells grown in 2D mono-layers simply do not replicate the complex interactions and architecture found in living organisms, which limits their use in basic life science research, toxicity testing, and drug discovery. n3D’s Bio-Assembler brings the simplicity of 2D culturing to 3D. 
The company’s Bio-Assembler is as simple as standard 2D techniques and faster than any other 3D cell culturing product currently available. Preparation time and cell manipulation requirements are equivalent to 2D culture. In fact, there are only two additional steps that differentiate the Bio-Assembler’s innovative 3D cell culturing process from 2D cell culturing: (1) Adding the Nanoshuttle to cells prior to levitation, and (2) Placing the magnetic drive on top of the cell culture plate. 
With the Bio-Assembler, easy-to-use reagents deliver biocompatible magnetic nanoparticles to cells, and magnetic</description>
  </item>

  <item>
    <title>Norstra Energy Corp. (NORX) First Well in Montana Bakken Now in Permitting Phase, Casing Should Set By July 18th</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180256</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180256</guid>
    <pubDate>Mon, 17 Jun 2013 17:13:25 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Norstra Energy reported today that they are all set to begin permitting and casing on the first well in their approximately 18k-acre block South Sun River Prospect, an over-pressure Bakken shale play in the heart of the Montana Bakken Fairway, Lewis &amp; Clark County.
Surveying now complete, NORX is in the permitting phase, with anticipation running high that we will see the permit come through during the interval from around July 1st to the 3rd. Excavation of the drill site is currently slated to commence after the July 4th holiday and sometime before the 11th, with the casing following shortly thereafter based on rig access, but with a tentative endpoint of the 18th. 
President and CEO of NORX, Glen Landry, underscored the successful proximal developments by majors like ARCO and Shell which have pierced nice Bakken sections here of striking similarity to Williston Basin targets. Landry further emphasized the potential of the area by pointing to the relevant seismic data, which offers us a clear picture of a</description>
  </item>

  <item>
    <title>Norstra Energy Corp. (NORX) First Well in Montana Bakken Now in Permitting Phase, Casing Should Set By July 18th</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180255</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180255</guid>
    <pubDate>Mon, 17 Jun 2013 17:13:05 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Norstra Energy reported today that they are all set to begin permitting and casing on the first well in their approximately 18k-acre block South Sun River Prospect, an over-pressure Bakken shale play in the heart of the Montana Bakken Fairway, Lewis &amp; Clark County.
Surveying now complete, NORX is in the permitting phase, with anticipation running high that we will see the permit come through during the interval from around July 1st to the 3rd. Excavation of the drill site is currently slated to commence after the July 4th holiday and sometime before the 11th, with the casing following shortly thereafter based on rig access, but with a tentative endpoint of the 18th. 
President and CEO of NORX, Glen Landry, underscored the successful proximal developments by majors like ARCO and Shell which have pierced nice Bakken sections here of striking similarity to Williston Basin targets. Landry further emphasized the potential of the area by pointing to the relevant seismic data, which offers us a clear picture of a</description>
  </item>

  <item>
    <title>Tri-Tech Holding, Inc. (TRIT) Announces Appointments and Retirements</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180248</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180248</guid>
    <pubDate>Mon, 17 Jun 2013 13:55:15 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Tri-Tech Holding recently announced some changes to its management. The company has appointed Brian McLellan as the General Manager of Tri-Tech Infrastructure, LLC, and also announced the retirement of former General Manager, Mr. James Schwartz. 
“Mr. Schwartz has been a valuable employee and a sincere friend to the Company. While we will miss him, we are glad that James will be able to spend more time away from work upon his retirement,” remarked Tri-Tech’s CFO and President, Mr. Phil Fan. “Mr. McClellan joined us in 2012 and served as Technical Director since. With his extensive experience, we are confident that Brian is the right individual to lead.”
With over 25 years of industry experience, Mr. McClellan is a knowledgeable engineering, sales, and management professional in the capital equipment and commercial production industries. Mr. McClellan has extensive knowledge in Process Engineering, Capital Equipment Sales, Production Management, Project Engineering/Management, Technical Service/Quality</description>
  </item>

  <item>
    <title>VistaGen Therapeutics, Inc. (VSTA) Shares Exciting CardioSafe 3D™ and LiverSafe 3D™ Developments at ISSCR’s 11th Annual Meeting</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180247</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180247</guid>
    <pubDate>Mon, 17 Jun 2013 13:54:38 GMT</pubDate>
    
    <category>Stocks</category>
    <description>VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, recently delivered an overview of key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Stem Cell Research (ISSCR), the largest forum for stem cell and regenerative medicine professionals from around the world, held last week in Boston, Massachusetts. 
Dr. Hai-Qing Xian, Senior Scientist, presented VistaGen’s poster entitled “Cardiotoxicity Assessment of Anti-Cancer Kinase Inhibitors using Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Assays,” which detailed important developments demonstrating that CardioSafe 3D™, VistaGen’s high throughput, human heart cell-based bioassay, is a clinically predictive system for preclinical cardiac safety screening of anti-cancer drug candidates, including small molecule kinase inhibitors (KIs), a new category of</description>
  </item>

  <item>
    <title>CEO of MELA Sciences, Inc. (MELA) Resigns, Robert Coradini to Fill in Temporarily</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180246</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180246</guid>
    <pubDate>Mon, 17 Jun 2013 13:53:45 GMT</pubDate>
    
    <category>Stocks</category>
    <description>MELA Sciences, a medical device company and developer of MelaFind(R), announced today that Joseph Gulfo has resigned as Chairman, President, Chief Executive Officer, and member of the Board of Directors. Member of the Board of Directors since December 2011, Robert Coradini will serve as interim CEO while the board hunts for a new Chief Executive Officer. Coradini has over 20 years of experience in the health care industry both leading and managing businesses for Johnson &amp; Johnson and GE Medical Systems, now known as GE Healthcare.
While at Johnson &amp; Johnson, Coradini held a variety of senior leadership positions. Acting as President of various subsidiaries of J&amp;J, including Lifescan, Cordis Endovascular, and Cardiovations (Ethicon), Coradini was the head of business development of the Medical Devices &amp; Diagnostics Group. Most recently he sat as President of New Ventures for the Johnson &amp; Johnson Consumer Group of Companies, overseeing the OrthoNeutrogena division, now known as Ortho Dermatologics after being</description>
  </item>

  <item>
    <title>Monster Arts, Inc. (MONT) Iconosys Receives Trademark for Word Bully&#174;, Anti-Cyberbullying Smartphone App</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180244</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180244</guid>
    <pubDate>Mon, 17 Jun 2013 10:04:57 GMT</pubDate>
    
    <category>Stocks</category>
    <description>Iconosys, subsidiary of Monster Arts and a developer of family safety, lifestyle, and entertainment Smartphone apps, today reported the formal registration of its trademark smartphone app, Word Bully&#174;, as well as received trademark status for Iconosys&#174;. This registration bolsters the company’s portfolio of intellectual property, protecting the company’s brands, technologies, apps, Web sites, merchandise, and licensing agreements. 
Word Bully&#174; was designed to address “cyberbullying,” which the company says is becoming more common in younger demographics, prompting legislation and awareness campaigns to thwart the practice. 
The app gives parents, guardians, and/or local authorities control over the content and tone of text messages, protecting children and teenagers from profane, inappropriate, life-threatening, terrorist, and bullying language via text message. 
Here’s how it works. When a text message triggers the Word Bully filter, a copy of the text is automatically sent to the monitoring parent (or</description>
  </item>

  <item>
    <title>The Aristocrat Group Corp. (ASCC) Launches Brand-Building Wholesale Initiative</title>
    <link>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180242</link>
    <guid>http://blogs.transworldnews.com/QualityStocks/Post.aspx?postID=180242</guid>
    <pubDate>Mon, 17 Jun 2013 10:03:45 GMT</pubDate>
    
    <category>Stocks</category>
    <description>The Aristocrat Group Corp. announced today that its wholesale subsidiary, TOP Shelf Distributing, is currently in the process of obtaining wholesaler licensing in one of the country’s top markets in the $21.3 billion U.S. spirits industry. 
Expanding business via distribution deals with international distillers and brewers is an important part of the company’s overall business strategy. The first product slated for wholesale by TOP Shelf is RWB Ultra-Premium Handcrafted Vodka, an all-American spirit with federal approval to advertise its gluten-free status right on the label. It’s scheduled for release in August. 
ASCC’s plans for its wholly owned distributor go much farther than that, however. It is anticipated that TOP Shelf Distributing will market additional outside distilled spirits brands as well as importing beer and wine for discerning consumers in select markets. 
“The explosion in niche spirits and microbrews in recent years has opened up a huge market of connoisseurs interested in a variety of</description>
  </item>

  </channel>
</rss>    




